Zoetis Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Zoetis Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Headquarters city: Parsippany
Headquarters state / province: New Jersey
Headquarters country: United States
Fiscal year end: December
Ticker symbol: ZTS
Primary stock exchange: NYSE

Identifiers

SEC CIK: 0001555280
EIN: 46-0696167
Wikidata ID: Q8073337

Board of directors

Follow this board

Antoinette Renee Leatherberry · Director
Since 2023
Frank A. Damelio · Director
Since 2023
Gavin Hattersley · Director
Since 2024
Gregory Norden · Director
Since 2023
Khosla Sanjay · Director
Since 2023
Kristin C. Peck · Director · Chief Executive Officer
Since 2023
Linda Rhodes · Director
Since 2023
Louise M. Parent · Director
Since 2023
Mark Stetter · Director
Since 2025
Michael B. Mccallister · Director
Since 2023
Paul Bisaro · Director
Since 2023
Robert W. Scully · Director
Since 2023
Stephanie Tilenius · Director
Since 2025
Vanessa Broadhurst · Director
Since 2023
Willie M. Reed · Director
Since 2023

Chief executives

Kristin C. Peck · Chief Executive Officer

Dates unknown

Director election results

Annual meeting of May 20, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

10 of this board's directors also sit on 16 other boards. 4 are in the same sector.

Shared director Other board Same sector

AT&T Inc.
via Michael B. Mccallister
BlackRock Inc.
via Kristin C. Peck
Chubb Limited
via Robert W. Scully
Direct Digital Holdings Inc.
via Antoinette Renee Leatherberry
Fidelity National Information Services Inc.
via Louise M. Parent
Fifth Third Bancorp
via Michael B. Mccallister
Hewlett Packard Enterprise Company
via Frank A. Damelio
Humana Inc.
via Frank A. Damelio
KKR & Co. Inc.
via Robert W. Scully
McCormick & Company Incorporated
via Gavin Hattersley
Molson Coors Beverage Company
via Gavin Hattersley
Myriad Genetics Inc. Same sector
via Paul Bisaro
Praxis Precision Medicines Inc. Same sector
via Gregory Norden
Royalty Pharma plc Same sector
via Gregory Norden
Seagate Technology Holdings PLC
via Stephanie Tilenius
Viatris Inc. Same sector
via Frank A. Damelio

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $886,384; 3 purchases by 3 insiders
Sold, last 12 months: $2,540,972; 2 sales by 1 insider

Date	Insider	Transaction	Shares	Price	Value
Sep 30, 2026	FULLER JULIE Officer (Executive Vice President)	Option exercise	+799	—	—
Sep 30, 2026	FULLER JULIE Officer (Executive Vice President)	Shares withheld for tax	−274	$69.83	$19,133
Aug 7, 2026	Frank A. Damelio Director	Gift	−6,650	—	—
Jun 10, 2026	Michael B. Mccallister Director	Gift	−1,209	—	—
May 21, 2026	Mark Stetter Director	Option exercise	+1,572	—	—
May 20, 2026	Louise M. Parent Director	Option exercise	+1,944	—	—
May 20, 2026	Louise M. Parent Director	Option exercise	+10,186	—	—
May 13, 2026	Frank A. Damelio Director	Open-market purchase	+6,650	$75.39	$501,344
May 13, 2026	Paul Bisaro Director	Open-market purchase	+2,000	$75.88	$151,760
May 11, 2026	Michael B. Mccallister Director	Open-market purchase	+3,000	$77.76	$233,280
Apr 30, 2026	Esch Kevin Officer (Executive Vice President)	Option exercise	+259	—	—
Apr 30, 2026	Esch Kevin Officer (Executive Vice President)	Shares withheld for tax	−75	$114.97	$8,623
Mar 31, 2026	Sarbaugh Keith Officer (Executive Vice President)	Option exercise	+1,528	—	—
Mar 31, 2026	Sarbaugh Keith Officer (Executive Vice President)	Shares withheld for tax	−524	$118.21	$61,942
Mar 9, 2026	Gregory Norden Director	Gift	−1,213	—	—

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Zoetis Inc.

Who is the CEO of Zoetis Inc.?

Kristin C. Peck is Zoetis Inc.'s Chief Executive Officer.

How many directors are on Zoetis Inc.'s board?

Zoetis Inc.'s board has 15 directors: Antoinette Renee Leatherberry, Frank A. Damelio, Gavin Hattersley, Gregory Norden, Khosla Sanjay, Kristin C. Peck, Linda Rhodes, Louise M. Parent, Mark Stetter, Michael B. Mccallister and 5 others.

Are Zoetis Inc. insiders buying or selling shares?

Over the last 12 months, Zoetis Inc. insiders bought $886,384 of shares in 3 purchases and sold $2.5 million of shares in 2 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Zoetis Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="zoetis-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.